Relationship of flow-volume curve pattern on pulmonary function test with clinical and radiological features in idiopathic pulmonary fibrosis. by NAKAGAWA Hiroaki et al.
Relationship of flow-volume curve pattern on
pulmonary function test with clinical and
radiological features in idiopathic pulmonary
fibrosis.
著者 NAKAGAWA Hiroaki, OTOSHI Ryota, ISOMOTO
Kohsuke, KATANO Takuma, BABA Tomohisa, KOMATSU
Shigeru, HAGIWARA Eri, NAKANO Yasutaka,










This article is licensed under a Creative Commons Attribution 4.0 International License, which permits
use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons
licence, and indicate if changes were made. The images or other third party material in this article
are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to
the material. If material is not included in the article's Creative Commons licence and your intended
use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit
http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
RESEARCH ARTICLE Open Access
Relationship of flow-volume curve pattern
on pulmonary function test with clinical
and radiological features in idiopathic
pulmonary fibrosis
Hiroaki Nakagawa1,2* , Ryota Otoshi2, Kohsuke Isomoto3, Takuma Katano2, Tomohisa Baba2, Shigeru Komatsu2,
Eri Hagiwara2, Yasutaka Nakano1, Ichiro Kuwahira4 and Takashi Ogura2
Abstract
Background: The flow-volume (FV) curve pattern in the pulmonary function test (PFT) for obstructive lung diseases
is widely recognized. However, there are few reports on FV curve pattern in idiopathic pulmonary fibrosis (IPF). In
this study, we investigated the relationship between FV curve pattern and clinical or radiological features in IPF.
Methods: The FV curves on PFTs and chest high-resolution computed tomography (HRCT) images of 130 patients
with IPF were retrospectively evaluated. The FV curves were divided into four groups based on the presence or
absence of the convex and concave patterns: convex/concave, non-convex/concave, convex/non-concave, and
non-convex/non-concave. Using a computer-aided system, CT honeycombing area (%HA) and subtracted low
attenuation area (%sLAA) were quantitatively measured. To assess the distribution of CT findings, the lung area was
divided into upper, lower, central, and peripheral areas. The relationships of FV curve patterns with patient
characteristics, spirometry results, and quantitative CT findings were evaluated.
Results: The patients with convex pattern was identified in 93 (71.5%) and concave pattern in 72 (55.4%). Among
the four groups, patients with the convex/non-concave pattern had significantly lower forced vital capacity (FVC)
and higher %HA of the upper/peripheral lung area (p = 0.018, and p = 0.005, respectively). The convex/non-concave
pattern was a significant predictor of mortality for IPF (hazard ratio, 2.19; p = 0.032).
Conclusions: Patients with convex/non-concave pattern in FV curve have lower FVC and poorer prognosis with
distinct distribution of fibrosis. Hence, FV curve pattern might be a useful predictor of mortality in IPF.
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Background
Idiopathic pulmonary fibrosis (IPF) is a specific form of
chronic and progressive fibrosing interstitial pneumonia
of unknown cause [1–3]. Baseline pulmonary function
test (PFT) values are reportedly associated with survival
in IPF, with forced vital capacity (FVC) and diffusing
capacity for carbon monoxide (DLCO) used as predictors
of survival [4–8]. In particular, FVC is widely used to as-
sess the severity and predict mortality in IPF [4, 5].
However, in patients having both IPF and expansive em-
physema, FVC may not be an appropriate indicator of
the severity of IPF [9].
In another aspect of the PFT, the flow-volume (FV)
curve demonstrates a portion of the respiratory dynam-
ics. If the FV curve exhibits a concave pattern, it indi-
cates that the patient’s airway is obstructed during
exhalation and an obstructive ventilatory disorder is
present. The concave pattern is typical in cases of severe
asthma and severe chronic obstructive pulmonary dis-
ease (COPD) [10, 11]. Conversely, a convex pattern of
the FV curve has been reported in interstitial lung dis-
ease (ILD) [12]. A previous study reported the presence
of increased elastic recoil forces and decreased dynamic
airway compression in the large bronchi in ILD [12].
These patterns have been classified by visual inspection
without clear definition. However, in patients having
both expansive fibrosis and emphysema, we cannot
visualize the pattern of the FV curve.
To the best of our knowledge, so far, there has been
only one report on FV curves in IPF [12]. In the present
study, we aimed to clarify the relationship between FV
curve pattern and clinical or radiological features in IPF.
Methods
Study design and patients
All patients with IPF—diagnosed in accordance with the
2011 IPF guidelines [13]—who visited the outpatient
clinic of our hospital between April 2012 and March
2015 were enrolled in this study. Patients with secondary
interstitial pneumonitis (such as collagen vascular dis-
ease, pneumonia caused by occupational or environmen-
tal exposure, chronic hypersensitivity pneumonitis, and
drug-induced pneumonia), combined pulmonary fibrosis
and emphysema (CPFE), and pleuroparenchymal fibroe-
lastosis (PPFE) were excluded. Patients who had not
undergone a PFT and high-resolution computed tomog-
raphy (HRCT) within three months from the first visit
were excluded. Patients whose PFT was presence of
cough in the FV curve were also excluded. Mortality and
survival data up to December 31, 2017, were collected.
The study protocol conformed to the Declaration of
Helsinki and was approved by the ethics committee of
Kanagawa Cardiovascular and Respiratory Center (ap-
proval number KCRC-17-0027). The need for informed
consent was waived because of the retrospective study
design.
To evaluate what FV curve meant in IPF, the classifi-
cation of FV curve was performed using the following
steps: 1; dividing convex or non-convex with visual in-
spection, 2; dividing concave or non-concave with the
ratio of the maximal expiratory flows at 50 and 25% of
the FVC (MEF50/MEF25), 3; mixing these two shapes of
flow to create four groups. First, the patients’ FV curves
were independently reviewed by two thoracic physicians
(R.O. and K.I.) who were blinded to the clinical and
radiological data and all other PFT data, except the FV
curve. The two physicians visually evaluated the FV
curves and classified the pattern as convex or non-
convex, as previously described [14, 15] (Fig. 1). In cases
of conflict between the two reviewers, a third thoracic
physician (T.K.) made the decision. Second, toevaluate
the presence of peripheral airway obstruction, MEF50/
MEF25 was calculated. The FV curve patterns were again
divided into two categories based on the MEF50/MEF25
ratio, with MEF50/MEF25 ≥ 4 defined as the concave pat-
tern and MEF50/MEF25 < 4 defined as the non-concave
pattern (Fig. 1). Third, we divided into four groups based
on the presence or absence of the convex pattern and
the concave pattern. The patient groups with the con-
vex/concave pattern, non-convex/concave pattern, con-
vex/non-concave pattern, and non-convex/non-concave
pattern were defined as A group, B group, C group, and
D group, respectively (Fig. 1). Composite physiologic
index (CPI) and gender, age, and physiology stage (GAP
stage) were determined as previously described [16, 17].
The PFTs had been performed in accordance with the
Japanese Respiratory Society guidelines [18].
Chest HRCT images were acquired using the Toshiba
Aquillion ONE (Toshiba Medical Systems Corp., Ota-
wara, Tochigi, Japan). These images were reconstructed
with 0.5–1.0 mm slice thickness and 10-mm intervals. A
computer-aided method for quantitative CT analysis of
honeycombing area was used to automatically measure
honeycombing areas on whole HRCT images, as previ-
ously described [19]. In brief, low-attenuation areas
enclosed by thick walls were extracted as honeycombing
areas, and the sum of honeycombing areas in all slices
was calculated as the HA. This HA included traction
bronchiectasis. Next, the low attenuation area (LAA)
was measured, as previously described [20, 21]. This
LAA included not only the emphysematous area, but
also the honeycombing area and traction bronchiectasis
in IPF. We calculated the pure emphysematous area as
the subtracted LAA (sLAA), which was obtained by sub-
tracting the HA from the LAA (Fig. 2). The HA and
sLAA as a percentage of the lung area were also calcu-
lated (%HA and %sLAA, respectively). To evaluate the
distribution of these CT findings, we divided the lung
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Fig. 1 Flow-volume curves of four patients with idiopathic pulmonary fibrosis. a A 68-year-old woman with the convex/concave pattern (A-group;
%FVC; 86.1%, %FEV1: 89.3%, and MEF50/MEF25-ratio: 5.27). b A 79-year-old man with the non-convex/concave pattern (B-group; %FVC: 74.1%, %FEV1:
76.6%, and MEF50/MEF25-ratio: 4.31). c An 84-year-old man with the convex/non-concave pattern (C-group; %FVC: 89.0%, %FEV1: 109.2%, and MEF50/
MEF25-ratio: 1.99). d A 75-year-old man with the non-convex/non-concave pattern (D-group; %FVC: 82.4%, %FEV1: 77.4%, and MEF50/MEF25-ratio: 3.11)
Fig. 2 Quantitative computed tomography (CT) analysis in a 65-year-old man with idiopathic pulmonary fibrosis. a and e Original CT image acquired at the
level of the upper and the lower lungs using the lung window setting. b and f Honeycombing area (HA) detected as a low attenuation area surrounded by a
thick wall. c and g Low attenuation area (LAA) detected as under − 960 HU. d and h Subtracted low attenuation area (sLAA) calculated by subtracting the HA
from the LAA
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area into four areas. First, the location of the tracheal bi-
furcation was used to divide the lung into the upper and
lower areas. Second, the 15-pixel area on the pleural side
was defined as the peripheral lung area, and the other
areas constituted the central lung area (Fig. 3). A public
domain computer program, ImageJ (Version 1.46. Na-
tional Institutes of Health, Bethesda, MD, USA) was
used for the quantitative CT analysis.
Statistical analysis
The interobserver agreement regarding the classification
of the FV curve pattern was evaluated using the kappa
statistic. The clinical and radiological variables were
compared using the Mann–Whitney U test, Kruskal
Wallis test, and the chi-square test. Predictors of time to
death were determined using the Cox proportional haz-
ards analysis. Survival analysis was also performed in ac-
cordance with the method of Kaplan–Meier, with the
endpoint being death. Differences in mortality were
assessed using the log-rank test. All statistical analyses
were performed using JMP version 9.0.2 (SAS Institute,




Of the 191 consecutive patients with IPF who visited the
outpatient clinic of our hospital between April 2012 and
March 2015, 30 patients were excluded because of the
absence of HRCT images or PFT results obtained within
three months from the first visit. Another 31 patients
were excluded because of the presence of cough in the
FV curve. Thus, 130 patients with IPF were finally en-
rolled in this study. The demographic, clinical, and
physiologic characteristics of these 130 patients are
summarized in Table 1. The median age of the study
group was 71 (65–76) years. Most of the patients (104
patients; 80.0%) were men and were either current
smokers or had a history of smoking (102 patients;
78.5%). The median %predicted FVC, forced expiratory
volume in 1 s (FEV1), and DLCO were 76.2, 76.3, and
70.1%, respectively. The median CPI was 31.3 (18.2–
45.4). Seventy-one (57.3%) patients were classified as
GAP stage I, 50 (40.3%) as stage II, and 3 (2.4%) as stage
III. The median follow-up period was 3.0 (1.4–3.8) years.
Flow-volume curve pattern analysis
Of the 130 patients, 93 (71.5%) patients had a convex pat-
tern of the FV curve. The agreement between the two
physicians was excellent for the convex pattern (kappa =
0.86). There were significant differences between patients
with convex and non-convex patterns in gender, body
mass index (BMI), and smoking history (in pack-years),
but not in FVC, DLCO, or CPI (Table 2).
The concave pattern was observed in 72 (55.4%) pa-
tients. Significant differences were noted between the
concave and non-concave patterns in age, BMI, FVC,
and CPI, but not in FEV1 or DLCO (Table 3).
The numbers of patients in A group, B group, C
group, and D group were 47, 25, 46, and 12, respectively
(Table 4). There were significant differences between
these groups in BMI and FVC (p < 0.001, and p = 0.018,
respectively), but not in FEV1, DLCO, or CPI.
Fig. 3 Quantitative computed tomography (CT) analysis for peripheral
and central lung area in the same patient presented in Fig. 2. a and c
Peripheral lung area calculated as a 15-pixels area on the pleural side.
b and d Central lung area calculated by removing the peripheral lung
area from the whole lung area
Table 1 Demographic, Clinical, and Physiologic Characteristics
of Patients with Idiopathic Pulmonary Fibrosis
Characteristics N Value
Age, years 130 71 (65–76)
Gender (Male/Female) 130 104 (80.0%)/26 (20.0%)
BMI, kg/m2 130 23.1 (20.7–25.9)
Smoking history
(current or past/never)
130 102 (78.5%)/28 (21.5%)
Pack-years 130 30 (2–46)
FVC %pred., % 130 76.2 (63.9–89.1)
FEV1%pred., % 130 76.3 (65.8–90.2)
FEV1/FVC, % 130 83.0 (76.8–87.8)
DLCO %pred., % 124 70.1 (50.8–85.7)
CPI 124 31.3 (18.2–45.4)
KL-6, U/ml 129 956 (623–1506)
GAP stage (I/II/III) 124 71 (57.3%)/50 (40.3%)/3 (2.4%)
Follow-up period, years 130 3.0 (1.4–3.8)
Data are presented as number or median (interquartile range)
BMI body mass index, FVC forced vital capacity, FEV1 forced expiratory volume
in 1 s; DLCO, diffusing capacity of the lungs for carbon monoxide, CPI
composite physiologic index, KL-6 Krebs von den Lungen-6, GAP gender, age,
and physiology
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CT image quantitation of honeycombing area and
emphysematous area
The median (interquartile range) %HA and %sLAA were
3.0% (1.3–5.1%) and 6.0% (3.5–9.2%), respectively. There
were no significant differences between the convex and
non-convex patterns in terms of the %HA and %sLAA
(Table 5). In contrast, significant differences were found
between the concave and non-concave patterns only in
the %HA (p = 0.009, Table 6). Among the four groups,
significant differences were observed only in the %HA
(p = 0.046, Table 7).
Among the CT findings, only the %HA of the upper/
peripheral lung area was significantly different among
the four groups (p = 0.005, Table 7); no intergroup dif-
ferences were observed in the %sLAA of any lung area.
Prediction of mortality based on flow-volume curve
patterns
The Kaplan-Meier survival curve demonstrated a signifi-
cant difference between the concave and non-concave
patterns, but not between the convex and non-convex
patterns (Fig. S1A, S1B). Among the four groups, pa-
tients in C group had the worst survival rates (Fig. S1C).
The survival curve also showed a significant difference
in mortality between C group and non-C group (log-
rank test; p = 0.010, Fig. 4). In the Cox hazard regression
analysis adjusted for age, gender, BMI, and smoking his-
tory in terms of pack-years, the C group was a signifi-
cant predictor of mortality for IPF (hazard ratio, 2.19;
95% confidence interval [CI]: 1.07–4.49; p = 0.032,
Table 8).
Table 2 Comparison of Clinical Features Between Convex Pattern and Non-convex Pattern of Flow-volume Curve
Convex pattern (n = 93) Non-convex pattern (n = 37) p value
Age, years 72 (65–77) 69 (64–75) 0.183
Gender (male/female) 70 (75.3%)/23 (24.7%) 34 (91.9%)/3 (8.1) 0.033*
BMI, kg/m2 22.4 (20.2–24.7) 23.6 (22.9–28.8) < 0.001
Pack-years 26 (0–41) 39 (21–60) 0.007
FVC %pred., % 76.1 (62.6–89.2) 78.8 (65.7–89.4) 0.488
FEV1%pred., % 79.2 (68.3–92.8) 71.3 (64.5–84.3) 0.059
DLCO %pred., % 70.1 (50.2–87.6)** 68.4 (54.4–77.9) 0.552
CPI 31.8 (19.1–47.6)** 31.5 (17.6–43.5) 0.755
KL-6, U/ml 960 (603–1717)*** 953 (628–1458) 0.460
GAP stage 1 (1–2)** 1 (1–2) 0.377
Data are presented as number or median (interquartile range)
p values derived by Mann–Whitney U test. *p values derived by chi-square test
**n = 87 and ***n = 92
BMI body mass index, FVC forced vital capacity, FEV1 forced expiratory volume in 1 s, DLCO diffusing capacity of the lungs for carbon monoxide, CPI composite
physiologic index, KL-6 Krebs von den Lungen-6, GAPs gender, age, and physiology
Table 3 Comparison of Clinical Features Between Concave Pattern and Non-concave Pattern of Flow-volume Curve
Concave pattern (n = 72) Non-concave pattern (n = 58) p value
Age, years 69 (63–75) 73 (66–77) 0.034
Gender (male/female) 58 (80.6%)/14 (19.4%) 46 (79.3%)/12 (20.7%) 0.860*
BMI, kg/m2 23.9 (22.1–26.5) 21.1 (19.8–23.5) < 0.001
Pack-years 30 (4–46) 25 (1–47) 0.558
FVC %pred., % 79.7 (68.4–92.9) 68.1 (59.1–86.2) 0.011
FEV1%pred., % 75.9 (66.2–89.2) 76.9 (64.1–92.8) 0.912
DLCO %pred., % 70.8 (53.8–84.0)** 67.7 (46.1–86.9)*** 0.330
CPI 28.7 (18.7–40.9)** 35.8 (18.3–50.3)*** 0.039
KL-6, U/ml 956 (648–1476)**** 979 (565–1544) 0.919
GAP stage 1 (1–2)** 2 (1–2) *** 0.033
Data are presented as number or median (interquartile range)
p values derived by Mann–Whitney U test. *p values derived by chi-square test
**n = 70, ***n = 54, and ****n = 71
BMI body mass index, FVC forced vital capacity, FEV1 forced expiratory volume in 1 s, DLCO diffusing capacity of the lungs for carbon monoxide, CPI composite
physiologic index, KL-6 Krebs von den Lungen-6, GAP gender, age, and physiology
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Discussion
In this study, we investigated the relationship between
the FV curve patterns on the PFT with clinical and
radiological features in patients with IPF. Our results
demonstrated that the patients in C group, with a con-
vex/non-concave pattern, had higher mortality rates
than those in the other groups, and suggested that this
pattern may be a prognostic factor in IPF.
We first divided the patterns of the FV curve into two
categories based on visual inspection: convex and non-
convex. Initially, we assumed that the convex pattern
was associated with more severe fibrosis than the non-
convex pattern. However, there were no significant dif-
ferences between the two types in any of the PFT values
or CPI. Furthermore, the degree of fibrosis and emphy-
sema evaluated using quantitative CT analysis were also
similar between the two patterns. Next, we categorized
the FV curve pattern into two other categories based on
the MEF50/MEF25 ratio. We expected that the concave
pattern would have more emphysematous lesions than
the non-concave pattern. However, there were no sig-
nificant differences between the two patterns in the










Age, years 68 (63–76) 69 (64–75) 73 (69–78) 71 (63–75) 0.104
Gender (male/female) 35/12 23/2 35/11 11/1 0.203*
BMI, kg/m2 23.6 (21.4–26.0) 25.4 (23.1–29.3) 20.8 (19.5–23.5) 23.0 (20.7–25.3) < 0.001
Pack-years 27 (0–40) 40 (22–56) 19 (0–44) 38 (8–70) 0.064
FVC %pred., % 81.4 (68.2–98.4) 76.2 (67.1–86.7) 67.0 (57.9–84.4) 81.2 (65.1–98.8) 0.018
FEV1%pred., % 81.1 (69.9–93.8) 68.2 (64.8–80.0) 76.3 (65.2–91.4) 78.2 (63.8–98.8) 0.103
DLCO %pred., % 73.8 (53.1–86.6) ** 69.6 (55.1–82.4) 68.8 (46.2–90.2)*** 71.3 (43.2–77.7) 0.812
CPI 27.3 (19.7–40.7)** 31.1 (14.6–41.3) 35.8 (17.1–49.9)*** 29.3 (21.7–49.8) 0.226
KL-6, U/ml 935 (686–1568) 960 (467–1519) 1070 (502–1776) 918 (652–1088) 0.883
GAP stage 1 (1–2)** 1 (1–2) 2 (1–-2)*** 2 (1–2) 0.125
Data are presented as number or median (interquartile range)
p values derived by Kruskal-Wallis test. *p values derived by chi-square test
**n = 45, and ***n = 42
A group, the patients with the convex/concave pattern of flow volume curve; B group, the non-convex/concave pattern; C group, the convex/non-concave
pattern; D group, the non-convex/non-concave pattern
BMI body mass index, FVC forced vital capacity, FEV1 forced expiratory volume in 1 s, DLCO diffusing capacity of the lungs for carbon monoxide, CPI composite
physiologic index, KL-6 Krebs von den Lungen-6, GAP gender, age, and physiology
Table 5 Comparison of Radiological Features Between Convex Pattern and Non-convex Pattern of Flow-volume Curve
Convex pattern (n = 93) Non-convex pattern (n = 37) p value
Total lung area, L 3.52 (2.92–4.20) 3.56 (3.09–4.18) 0.630
HA, ml 115 (56–173) 93 (46–132) 0.247
%HA, % 3.2 (1.4–5.9) 2.7 (1.2–4.2) 0.263
sLAA, ml 207 (103–372) 227 (135–424) 0.191
%sLAA, % 5.9 (3.2–8.8) 6.0 (4.3–9.9) 0.150
Upper/peripheral %HA, % 2.1 (0.8–4.3) 1.4 (0.7–2.6) 0.095
Upper/central %HA, % 0.2 (0.0–0.6) 0.1 (0.0–0.2) 0.293
Lower/peripheral %HA, % 5.7 (3.2–9.5) 5.6 (2.8–7.6) 0.364
Lower/central %HA, % 1.2 (0.2–3.5) 0.9 (0.3–3.0) 0.716
Upper/peripheral %sLAA, % 6.7 (3.9–9.7) 7.5 (5.4–12.0) 0.103
Upper/central %sLAA, % 7.0 (4.2–11.2) 8.5 (5.2–14.4) 0.153
Lower/peripheral %sLAA, % 4.7 (2.4–7.5) 5.2 (3.3–7.7) 0.260
Lower/central %sLAA, % 5.1 (2.8–8.2) 6.0 (3.7–9.5) 0.158
Data are presented as median (interquartile range)
p values derived by Mann–Whitney U test
%HA, computed-tomography-derived %honeycombing area; %sLAA, computed-tomography-derived %subtracted low attenuation area
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degree of emphysema. Based on these results, we hy-
pothesized that not only the degree, but also the distri-
bution of radiological findings would affect the patterns
of the FV curve. The additional quantitative CT analysis
revealed a significant difference among the four groups
in the %HA of the upper/peripheral lung area.
The concave pattern, i.e., MEF50/MEF25-ratio ≥ 4, is re-
portedly affected by peripheral airway obstruction [22,
23]. However, the concave pattern in our study was not
associated with %FEV1 or %sLAA. The obstruction of
the peripheral airways due to emphysematous change
may be prevented by traction bronchiectasis around the
peripheral airway; thus, the concave pattern may be lost.
In the additional analysis of the %HA/%sLAA ratio, the
ratio of the upper/peripheral lung area significantly af-
fected the concave pattern of the FV curve (Table S1).
The concave pattern of the FV curve in IPF may depend
on both the degree and the distribution of fibrosis.
The convex pattern has been reported in patients with
ILD [12] and is more common among young people [14,
Table 6 Comparison of Radiological Features Between Concave Pattern and Non-concave Pattern of Flow-volume Curve
Concave pattern (n = 72) Non-concave pattern (n = 58) p value
Total lung area, L 3.60 (3.16–4.28) 3.47 (2.81–4.04) 0.161
HA, ml 83 (44–151) 118 (75–187) 0.017
%HA, % 2.4 (1.2–4.1) 3.5 (2.1–6.5) 0.009
sLAA, ml 205 (119–363) 220 (73–418) 0.881
%sLAA, % 5.9 (3.7–8.0) 6.0 (2.9–11.0) 0.815
Upper/peripheral %HA, % 1.2 (0.6–2.9) 2.4 (1.2–5.2) 0.001
Upper/central %HA, % 0.1 (0.0–0.3) 0.2 (0.0–0.7) 0.048
Lower/peripheral %HA, % 4.6 (2.8–7.6) 6.6 (4.2–10.2) 0.029
Lower/central %HA, % 0.7 (0.2–2.3) 1.7 (0.5–4.0) 0.022
Upper/peripheral %sLAA, % 6.8 (4.5–9.8) 6.5 (3.8–11.2) 0.538
Upper/central %sLAA, % 7.2 (4.7–11.2) 7.6 (3.6–12.7) 0.687
Lower/peripheral %sLAA, % 4.6 (2.9–7.1) 5.1 (2.5–8.7) 0.558
Lower/central %sLAA, % 4.9 (3.4–7.6) 6.0 (2.6–10.1) 0.579
Data are presented as median (interquartile range)
p values derived by Mann–Whitney U test
%HA, computed-tomography-derived %honeycombing area; %sLAA, computed-tomography-derived %subtracted low attenuation area










Total lung area, L 3.64 (3.19–4.40) 3.56 (2.98–3.96) 3.43 (2.72–3.99) 3.67 (3.21–4.86) 0.270
HA, ml 81 (44–157) 84 (43–141) 124 (75–193) 101 (72–130) 0.085
%HA, % 2.4 (1.2–4.0) 2.3 (1.2–4.5) 4.2 (2.1–6.8) 3.1 (2.2–4.1) 0.046
sLAA, ml 207 (110–375) 180 (135–337) 203 (69–372) 389 (115–553) 0.264
%sLAA, % 6.1 (3.4–8.0) 5.7 (4.3–8.0) 5.6 (2.7–9.4) 9.1 (3.5–15.7) 0.291
Upper/peripheral %HA, % 1.2 (0.6–2.9) 1.4 (0.5–2.7) 3.1 (1.3–5.5) 1.5 (1.1–2.5) 0.005
Upper/central %HA, % 0.1 (0.0–0.4) 0.1 (0.0–0.2) 0.2 (0.1–1.0) 0.1 (0.0–0.2) 0.069
Lower/peripheral %HA, % 4.7 (2.9–7.4) 4.5 (2.6–7.7) 7.1 (3.9–11.5) 5.8 (4.6–6.8) 0.131
Lower/central %HA, % 0.7 (0.2–2.1) 0.9 (0.2–2.6) 1.7 (0.6–4.1) 0.8 (0.3–3.3) 0.113
Upper/peripheral %sLAA, % 6.8 (4.2–9.7) 6.7 (5.9–10.9) 6.0 (3.7–6.0) 10.1 (4.0–14.1) 0.297
Upper/central %sLAA, % 7.1 (4.7–11.1) 7.7 (6.0–13.4) 6.5 (3.6–11.9) 10.2 (3.3–17.5) 0.529
Lower/peripheral %sLAA, % 4.9 (2.5–7.7) 4.4 (3.2–6.8) 4.6 (2.3–7.6) 7.7 (4.2–12.8) 0.151
Lower/central %sLAA, % 5.0 (3.0–7.6) 4.7 (3.7–7.9) 5.8 (2.5–8.8) 8.5 (3.4–16.6) 0.304
Data are presented as number or median (interquartile range)
p values derived by Kruskal-Wallis test
A group, the patients with the convex/concave pattern of flow volume curve; B group, the non-convex/concave pattern; C group, the convex/non-concave
pattern; D group, the non-convex/non-concave pattern
%HA, computed-tomography-derived %honeycombing area; %sLAA, computed-tomography-derived %subtracted low attenuation area
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15]. A previous study reported increased elastic recoil
forces, decreased airway resistance, and decreased dy-
namic airway compression in the large bronchi in pa-
tients with ILD [12]. Patients with ILD may be able to
exhale strongly because of expanded peripheral airways
and fibrotic lung tissue. However, there were no signifi-
cant associations between the convex pattern and %FVC,
CPI, or %HA in our study. The convex pattern is attrib-
uted to a ‘choke point’ in the lower trachea, indicating
the flow-limiting area of the bronchial tree, and disap-
pears with increasing age as the choke point moves
further down the bronchi due to loss of lung elastic re-
coil [24]. To compare the degree of flow limitation be-
tween the convex and non-convex patterns, the speed of
expiration was evaluated (Table S2). The peak flow in
the convex pattern was significantly slower than that in
the non-convex pattern, while the FEV1 was similar be-
tween the two patterns. These results suggest that the
heterogeneity of the exhalation flow may make up the
choke point, indicating that the convex pattern may be
easily affected by the degree of traction bronchiectasis.
However, in this quantitative CT analysis, the HA in-
cludes both honeycombing lesions and traction bronchi-
ectasis lesions, and it is difficult to clearly distinguish
between these two lesion types [19]. This limitation of
quantitative CT analysis may be the reason why there
was no difference in the %HA between the convex and
non-convex patterns.
Among the four groups in our study, C group had a sig-
nificantly higher value of the %HA of the upper/peripheral
lung area than the other groups. The FV curve may be
easily affected by upper lung fibrosis because the upper
lung is close to the trachea and the main bronchi. Fibrosis
of the upper/peripheral lung area may reduce the periph-
eral airway obstruction and result in heterogeneous move-
ment of the thorax, thereby causing heterogeneous flow of
the exhalation and the choke point. These changes may be
explained by comparing peak expiration flow in the FV
curve between the four groups (Fig. S2).
The patients in C group had the worst prognoses in
our study. This may be because they required more
breathing effort due to heterogeneous movement of the
thorax, and the heterogeneous movement may have
caused a decrease in BMI. We cannot conclude whether
the change in the FV curve is the cause or the result of
the decrease in BMI. However, even in the analysis ad-
justed for BMI, the convex/non-concave pattern, as seen
in C group, was a significant predictor of mortality in
our study. Hence, we believe that this FV curve pattern
is associated with a poorer prognosis and reduced BMI.
Observation of the movement of the lung using 4D CT
analysis has been recently attracting attention [25]. Fu-
ture studies using a detailed analysis of lung movement
are warranted to prove and establish our hypothesis re-
garding the heterogeneous movement of the thorax in
this category of patients.
There were several limitations in the present study.
First, this was a retrospective study with a small sample
size, conducted at a single institution. Second, classifica-
tion of the FV curve patterns into convex or non-convex
patterns may not be completely objective. However, the
concordance rate between the two reviewers was excel-
lent. A prospective, multicenter study is needed to con-
firm the usefulness of FV curves in the prediction of
prognosis in patients with IPF.
Fig. 4 Kaplan–Meier plot of survival probability. The patients in the
C group (red line) had worse survival than those in the other groups
(blue line; log-rank test; p = 0.010)
Table 8 Results of Cox’s Hazard Regression Analysis for
Predictors of Mortality Adjusted by Age, Gender, BMI, and Pack-
year
HR 95% CI p value
C group (vs non-C group) 2.19 1.07–4.49 0.032
FVC %pred., % 0.97 0.94–0.99 0.002
FEV1%pred., % 0.99 0.97–1.01 0.289
DLCO %pred., % 0.97 0.95–0.99 0.002
CPI 1.05 1.02–1.08 < 0.001
GAP stage 1.93 0.98–3.74 0.057
KL-6, U/ml 1.00 1.00–1.00 0.360
%HA, % 1.26 1.13–1.40 < 0.001







HR hazard ratio, CI confidence interval, %HA computed-tomography-derived
%honeycombing area, %sLAA computed-tomography-derived %subtracted low
attenuation area, BMI body mass index, FVC forced vital capacity, FEV1 forced
expiratory volume in 1 s, DLCO diffusing capacity of the lungs for carbon
monoxide, CPI composite physiologic index, KL-6 Krebs von den Lungen-6,
GAP gender, age, and physiology
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Conclusions
The convex/non-concave pattern of the FV curve in IPF
may be associated with the degree of fibrosis in the
upper/peripheral lung area. The convex/non-concave
pattern of the FV curve and the degree of fibrosis in the
upper/peripheral lung area may be a predictor of mortal-
ity in patients with IPF. Therefore, we should pay atten-
tion not only to FVC and DLCO, but also to the pattern
of the FV curve and the distribution of fibrosis when
evaluating the PFT and HRCT in IPF.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12890-020-01254-z.
Additional file 1: Table S1. Comparison of %HA/%sLAA-ratio Between
Concave Pattern and Non-concave Pattern of Flow-volume Curve. Table
S2. Comparison of %HA/%sLAA-ratio Between Convex Pattern and Non-
convex Pattern of Flow-volume Curve. Figure S1. Kaplan-Meier plots of
survival probability. (A) The patients with a concave pattern (red line) had
better survival than those with a non-concave pattern (blue line; log-rank
test; p = 0.026). (B) There was no significant difference between the con-
vex pattern (red line) and non-convex pattern (blue line; log-rank test;
p = 0.234). (C) Mixed convex and concave patterns, i.e., the C group (blue
line), had worse survival than the other groups (A group: red line, B
group: green line, and D group: black line; log-rank test; p = 0.080). Fig-
ure S2. Median flow values at different expiratory flow levels in each
group. The flow values in the A group (blue line) and C group (green
line) had convex patterns. The forced expiration at the PEF level in the C
group was low compared with that in the other groups. PEF = peak ex-
piratory flow, MEF =maximal expiratory flow.
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